Why the study?
Does screening for hypertrophic cardiomyopathy prevent sudden death in young competitive athletes?
Population
Young competitive athletes
Design
Cohort
Authors
Loading...
HCM screening in athletes may still merit consideration; leaves open its net impact on sudden death prevention in this population.
Does screening for hypertrophic cardiomyopathy prevent sudden death in young competitive athletes?
Screening and disqualification of affected young competitive athletes may prevent sudden death, despite hypertrophic cardiomyopathy being an uncommon cause of mortality in this group.
Corrado et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: